Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients (Preedom)
This study has been completed.
Information provided by:
First received: October 1, 2008
Last updated: December 6, 2010
Last verified: December 2010
The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.
Gastroesophageal Reflux Disease
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients|
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Primary Outcome Measures:
- The primary variable is the total rate of GERD patients who had EED symptom and effect on their quality of life.
Secondary Outcome Measures:
- The secondary variable is the comparison of the EED symptom frequency in ERD and NERD patients.
|Study Start Date:||September 2008|
|Study Completion Date:||February 2009|
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00768196
|Korea, Republic of|
|Cheonan, Chungnam, Korea, Republic of|
|Seoul, Kyungkido, Korea, Republic of|
|Sungnam, Kyungkido, Korea, Republic of|
|Suwon, Kyungkido, Korea, Republic of|
Sponsors and Collaborators
|Study Director:||Joon-Woo Bahn||AstraZeneca Korea|